This HTML5 document contains 123 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-dehttp://de.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n14https://global.dbpedia.org/id/
n20http://portland.bizjournals.com/portland/stories/2007/10/29/
yagohttp://dbpedia.org/class/yago/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n21http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
n17http://www.grid.ac/institutes/
dbpedia-fahttp://fa.dbpedia.org/resource/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4https://
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Sarepta_Therapeutics
rdf:type
yago:SocialGroup107950920 yago:WikicatCompaniesEstablishedIn1980 yago:WikicatCompaniesBasedInCambridge,Massachusetts yago:Group100031264 yago:YagoLegalActor yago:Company108058098 yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity yago:WikicatPharmaceuticalCompaniesOfTheUnitedStates dbo:Organisation yago:WikicatCompaniesBasedInWashington(state) yago:DrugCompany108002578 wikidata:Q24229398 dbo:Agent yago:Institution108053576 n21:Agent n21:SocialPerson yago:Abstraction100002137 schema:Organization wikidata:Q43229 wikidata:Q4830453 dbo:Company yago:WikicatCompaniesListedOnNASDAQ owl:Thing yago:Organization108008335
rdfs:label
Sarepta Therapeutics Sarepta Therapeutics
rdfs:comment
Sarepta Therapeutics ist ein US-amerikanisches, medizinisches Forschungsunternehmen, das 1980 ursprünglich unter dem Firmennamen AntiVirals gegründet und 2012 in Sarepta umbenannt wurde. Sarepta hat seinen Hauptsitz in Cambridge, MA. Die europäische Zentrale befindet sich in Zug, Schweiz. Auch in Deutschland, Italien, Großbritannien, Irland, Schweden und Brasilien wurden 2018 Niederlassungen gegründet. An der amerikanischen Technologiebörse NASDAQ ist Sarepta unter dem Kennzeichen SRPT gelistet. Sarepta Therapeutics, Inc. (Nasdaq: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of the end of 2019, the company has two approved drugs (see the Products section below).
foaf:name
Sarepta Therapeutics, Inc.
foaf:homepage
n4:www.sarepta.com
dbp:name
Sarepta Therapeutics, Inc.
dcterms:subject
dbc:Health_care_companies_based_in_Massachusetts dbc:Orphan_drug_companies dbc:Companies_listed_on_the_Nasdaq dbc:Pharmaceutical_companies_of_the_United_States dbc:Companies_based_in_Cambridge,_Massachusetts dbc:Companies_established_in_1980 dbc:1980_establishments_in_Oregon dbc:Corvallis,_Oregon dbc:Life_sciences_industry dbc:Health_care_companies_based_in_Oregon
dbo:wikiPageID
2796300
dbo:wikiPageRevisionID
1122736836
dbo:wikiPageWikiLink
dbc:Health_care_companies_based_in_Massachusetts dbr:Influenza dbr:United_States dbr:Chief_executive_officer dbr:Duchenne_muscular_dystrophy dbr:Calicivirus dbr:Morpholino dbr:Defense_Threat_Reduction_Agency dbr:AVICINE dbr:Portland,_Oregon dbr:Severe_acute_respiratory_syndrome dbc:Orphan_drug_companies dbr:RNA_virus dbr:Pancreatic dbc:Pharmaceutical_companies_of_the_United_States dbr:Restenosis dbc:Companies_established_in_1980 dbc:Companies_listed_on_the_Nasdaq dbr:Messenger_RNA dbc:Companies_based_in_Cambridge,_Massachusetts dbr:Limb-Girdle_muscular_dystrophy dbr:West_Nile_virus dbr:Bothell,_Washington dbr:Dystrophin dbr:Drug_development dbr:Vaccine dbr:Marburg_virus dbr:Dengue_fever dbr:Eteplirsen dbr:Oligomer dbr:SARS dbr:Russell_1000_Index dbr:Angioplasty dbc:1980_establishments_in_Oregon dbr:Seattle dbr:Ebola dbc:Corvallis,_Oregon dbr:Rare_disease dbr:Golodirsen dbr:Antisense_therapy dbr:Medical_research dbr:Colorectal dbc:Health_care_companies_based_in_Oregon dbc:Life_sciences_industry dbr:Cambridge,_Massachusetts dbr:Hepatitis_C dbr:U.S._Department_of_Defense dbr:Gene_translation dbr:Corporation
dbo:wikiPageExternalLink
n20:daily16.html n4:www.sarepta.com
owl:sameAs
yago-res:Sarepta_Therapeutics dbpedia-fa:سارپتا n14:Woht wikidata:Q15109846 freebase:m.03p1km8 dbpedia-de:Sarepta_Therapeutics
dbp:wikiPageUsesTemplate
dbt:Official dbt:Pharmaceutical_companies_of_the_United_States dbt:Reflist dbt:Update dbt:Increase dbt:Portal dbt:Infobox_company dbt:Short_description
dbp:homepage
n4:www.sarepta.com
dbp:keyPeople
Douglas S. Ingram
dbp:revenue
3.01E8
dbp:tradedAs
NASDAQ:SRPT Russell 1000 Index component
dbo:abstract
Sarepta Therapeutics ist ein US-amerikanisches, medizinisches Forschungsunternehmen, das 1980 ursprünglich unter dem Firmennamen AntiVirals gegründet und 2012 in Sarepta umbenannt wurde. Sarepta hat seinen Hauptsitz in Cambridge, MA. Die europäische Zentrale befindet sich in Zug, Schweiz. Auch in Deutschland, Italien, Großbritannien, Irland, Schweden und Brasilien wurden 2018 Niederlassungen gegründet. An der amerikanischen Technologiebörse NASDAQ ist Sarepta unter dem Kennzeichen SRPT gelistet. Sarepta hat sich der Entdeckung und Entwicklung von präzise wirksamen Gentheraputika („precision genetic medicines“) zur Behandlung von seltenen neuromuskulären Erkrankungen verschrieben. In erster Linie treibt Sarepta die Entwicklung seiner Wirkstoffkandidaten zur Behandlung der Duchenne-Muskeldystrophie (DMD) voran. Sarepta Therapeutics, Inc. (Nasdaq: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of the end of 2019, the company has two approved drugs (see the Products section below).
skos:closeMatch
n17:grid.423097.b
prov:wasDerivedFrom
wikipedia-en:Sarepta_Therapeutics?oldid=1122736836&ns=0
dbo:wikiPageLength
11797
dbo:revenue
3.01E8
dbo:keyPerson
dbr:Chief_executive_officer
foaf:isPrimaryTopicOf
wikipedia-en:Sarepta_Therapeutics